Last update:
Coronavirus (COVID-19)
Molecular & Computational biology
'Time machine' enzyme could improve mRNA-based therapeutics
Researchers from the International Institute of Molecular and Cell Biology in Warsaw (IIMCB) have described a new mechanism that improves the efficiency of mRNA-based therapies. The research findings could facilitate the ...
18 hours ago
0
43
COVID-19 outbreak
Coronavirus disease 2019 (COVID-19) is the infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
A pneumonia of unknown cause detected in Wuhan, China was first reported to the World Health Organization Country Office in China on 31 December 2019 and recognised as a pandemic on 11 March 2020.
Reported illnesses have ranged from mild symptoms to severe illness and death for confirmed COVID-19 cases.
More information: WHO, CDC, global cases.
Follow us on Google News for the latest updates on the coronavirus.
Antiviral chewing gum shows promise in reducing influenza and herpes spread
In today's interconnected world, infectious diseases pose an escalating threat, as demonstrated by the coronavirus pandemic and outbreaks of H1N1, SARS, Ebola, Zika, and H5N1 (bird flu) viruses—all of which have had significant ...
Apr 5, 2025
0
106

Zooming in on the structure of the lethal Ebola virus
Six years before the start of the COVID-19 pandemic, an Ebola outbreak in West Africa had people fearing the possibility of a global outbreak. This was the first time many had ever heard of the virus, but since it was first ...
Mar 26, 2025
0
46

'Low-sugar' vaccine can provide broad immunity against coronavirus variants
Sugar coatings aren't only for candies; they also help viruses, like the ones that cause COVID-19, hide from their hosts' immune system. Now, researchers have developed a universal vaccine that targets coronaviruses and the ...
Mar 25, 2025
0
180

Cause of post-COVID inflammatory shock in children identified
MIS-C is a serious inflammatory shock that affects children. It can occur several weeks after a COVID infection and can be life-threatening. Until now, however, the precise cause of the condition was unknown.
Mar 12, 2025
0
100

Nanoparticle immune therapy shows potential to halt pancreatic cancer spread
Pancreatic cancer remains one of the most challenging tumors to treat, partly because it is often discovered at advanced stages when the disease has already spread, or metastasized. About half of pancreatic cancer patients ...
Mar 5, 2025
0
110

Antibody pair shows potential to defeat all SARS-CoV-2 variants
The virus that causes COVID-19 has been very good at mutating to keep infecting people—so good that most antibody treatments developed during the pandemic are no longer effective. Now a team led by Stanford University researchers ...
Mar 5, 2025
0
46

Contamination detection tool merges synthetic biology and nanotech for ultrasensitive water testing
A platform developed nearly 20 years ago previously used to detect protein interactions with DNA and conduct accurate COVID-19 testing has been repurposed to create a highly sensitive water contamination detection tool.
Feb 27, 2025
0
21

Idaho law allows over-the-counter sale of controversial drug ivermectin
It was a scene that doctors saw play out over and over during the COVID-19 pandemic, said David Pate, the former president and CEO of St. Luke's Health System.
Apr 17, 2025
0
2

Most COVID-19 treatments found to be free of serious side effects in analysis of US studies
Numerous treatment options for COVID-19 have been approved by the U.S. Food and Drug Administration over the last four years, including antiviral drugs and monoclonal antibodies that suppress an excessive immune response. ...
Apr 11, 2025
0
29

Students perform equally well in-person or online, study finds
For academic performance, it doesn't matter whether students attend a lecture in person, stream it, or watch it later. The key is that they can choose for themselves and actively participate. This is shown by research from ...
Apr 10, 2025
0
0

Federal government pulls back $11.4B in COVID health funds
The federal government is clawing back $11.4 billion in COVID funding, a move that could affect local and state public health efforts across the country.
Mar 26, 2025
0
0

Early pandemic vulnerability to severe COVID identified for certain immune system genotypes
Imagine a previously unknown bug—new to our immune defenses—that suddenly emerged and rapidly spread all over the globe, causing the deaths of millions and an economic breakdown due to the interruption of work in virtually ...
Mar 20, 2025
0
0

Long COVID could be costing U.S. between $2 billion and $6.5 billion annually
The current number of long COVID-19 cases may already be costing the U.S. $2.01–6.56 billion dollars per year, according to a study recently published in the Journal of Infectious Diseases.
Mar 19, 2025
1
4

'Nobody knew exactly what to do': Five years on, what scientific lessons were learned during COVID?
The pandemic stretched us—our communication, our science, our distribution networks, even what it means to be a good citizen amid rapidly developing knowledge.
Mar 17, 2025
0
0

COVID-19 vaccination not linked to major structural birth defects
COVID-19 vaccination in early pregnancy (≤20 weeks of gestation) is not associated with increased prevalence of major structural birth defects, according to a study published online March 14 in Pediatrics.
Mar 14, 2025
0
0

Measles cases in Europe and Central Asia doubled last year to the highest reported level since 1997
There were 127,350 measles cases reported in Europe and Central Asia in 2024, double the number of cases reported the previous year and the highest number since 1997, according to an analysis by the World Health Organization ...
Mar 13, 2025
0
0

Five years of COVID-19 underscore value of coordinated efforts to manage disease
Five years ago, on March 11, 2020, the World Health Organization declared the outbreak of COVID-19 a global pandemic. The novel coronavirus, dubbed SARS-CoV-2, began as a "cluster of severe pneumonia cases of unknown cause" ...
Mar 11, 2025
0
0

From inflammation to fibrosis: Research explores cellular changes as COVID-19 lung damage worsens
Researchers have uncovered changes in the cellular response throughout lung damage caused by SARS-CoV-2—the virus behind COVID-19. The team revealed distinct phases where waves of immune responses give way to lung fibrosis—scarring ...
Mar 10, 2025
0
1
